Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Result
of your search per sponsor: Genzyme
Woman and Man Max 99 years
Genzyme Europe BV
Update Il y a 4 ans
Study to Evaluate the Dose, Safety and Effectiveness of Modified-Release Recombinant Human Thyroid Stimulating Hormone (MRrhTSH) When Used in Conjunction with Radioiodine for the Treatment of Multinodular Goiter
The objective of this study is to determine the dose-response and safety of 2 doses of MRrhTSH with radioiodine (131I) therapy to achieve goiter shrinkage and improve goiter symptoms compared with 131...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Genzyme Corporation
Update Il y a 4 ans
NeoGAA Extension Study
Long-term safety and pharmacokinetics (PK) of neoGAA
Country
None
organs
None
Specialty
None
unknown
More information
Woman and Man Max 99 years
Genzyme Corporation
Update Il y a 4 ans
Evaluation of efficacy and safety of vandetanib in patients with advanced papillary or poorly differentiated thyroid cancer
To determine the efficacy (as assessed by progression free survival (PFS) ) of vandetanib when compared to placebo in patients with differentiated thyroid cancer that is either locally advanced or met...
Country
None
organs
None
Specialty
None
unknown
More information
Woman and Man Max 99 years
Genzyme Europe B.V
Update Il y a 4 ans
A Prospective Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Mipomersen in Patients With Severe Hypercholesterolemia on a Maximally Tolerated Lipid-Lowering Regimen and Who are Not on Apheresis
To compare the safety and efficacy of 26 weekly, subcutaneous injections of mipomersen (200 mg) against placebo in treating severely hypercholesterolemic patients who are on a maximally tolerated lipi...
Country
None
organs
None
Specialty
None
Closed trial
More information
Man Max 99 years
Genzyme Corporation
Update Il y a 4 ans
Evaluate the Safety, Pharmacodynamics, Pharmacokinetics, and Exploratory Efficacy of GZ402671 in Treatment-naïve Adult Male Patients with Fabry Disease
To assess the safety, pharmacokinetics (PK), pharmacodynamics (PD), and exploratory efficacy of GZ402671 / SAR402671 in enzyme replacement therapy treatment-naïve adult male patients diagnosed with ...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Genzyme Europe BV
Update Il y a 4 ans
A Randomized, Double-Blind, Multicenter, Multinational, Placebo-Controlled Study of the Safety, Efficacy, and Pharmacokinetics of Myozyme, Recombinant Human Acid alpha-Glucosidase (rhGAA), Treatment in Patients with Late-Onset Pompe Disease
The overall objective is to evaluate the safety, efficacy, and pharmacokinetics (PK) of Myozyme treatment in patients with late-onset Pompe disease as compared to placebo. The primary objectives of...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Genzyme Europe BV
Update Il y a 4 ans
A Multicenter, Open-Label Study of Hectorol (doxercalciferol capsules) for the Treatment of Secondary Hyperparathyroidism in Stage 3 or Stage 4 Chronic Kidney Disease (CKD) Patients
To evaluate the safety and tolerability of Hectorol Capsules during 52 weeks of treatment in patients with Stage 3 or Stage 4 CKD
Country
None
organs
None
Specialty
None
unknown
More information
Woman and Man
Between 55 years
and 99 years
Genzyme
Update Il y a 4 ans
GENZYME CLO34100405 : Essai de phase 3, randomisé en double aveugle, comparant l’efficacité et la tolérance de la cytarabine associée ou non à de la clofarabine, chez des patients âgés ayant une leucémie aiguë myéloïde. [Informations issues du site clinicaltrials.gov et traduites par l'INCa] [essai clos aux inclusions]
A phase III randomized, double-blind, controlled study comparing clofarabine and cytarabine versus cytarabine alone in adult patients 55 years and older with acute myelogenous leukemia (AML) who have ...
Country
France
organs
Leucémies aiguës
Specialty
Chimiothérapie
,
Gériatrie
Essai clos aux inclusions
More information
Woman and Man Max 99 years
Genzyme Corporation
Update Il y a 4 ans
Open Label Study of Sargramostim Among Patients Receiving Myelosuppressive Induction Chemotherapy for Acute Myelogenous Leukemia
Measure the proportion of patients who develop binding and neutralizing antibodies in the blood after treatment with sargramostim following induction/reinduction chemotherapy.
Country
None
organs
None
Specialty
None
unknown
More information
Woman and Man Max 99 years
Genzyme GmbH
Update Il y a 4 ans
The Effectiveness of an Additional Course of Alemtuzumab in Relapsing Remitting Multiple Sclerosis Patients After 2 Courses of Alemtuzumab
Evaluation of effectiveness of an additional alemtuzumab course in patients with relapsing remitting multiple sclerosis (RRMS) with disease activity after 2 courses.
Country
None
organs
None
Specialty
None
unknown
More information
Previous
1
2
3
4
5
6
Next